Citation: | ZHAO Songge, ZHANG Xiaoyu, YANG Yanwei, MENG Xiangzhe, YANG Huanmei, XI Risheng, CAO Wenjuan. Efficacy of probiotics combined with montelukast in treatment of children with Mycoplasma pneumoniae pneumonia complicated with myocardial injury[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 48-52. DOI: 10.7619/jcmp.20231630 |
To observe the therapeutic effect of probiotics combined with montelukast in children with Mycoplasma pneumoniae pneumonia (MPP) complicated with myocardial injury.
A total of 102 children with MPP and myocardial injury were selected as the study objects, and were randomly divided into control group and observation group, with 51 cases in each group. The control group was treated with montelukast, and the observation group was treated with probiotics based on the control group. The clinical efficacy, symptom resolution time, hospital stay, myocardial injury index, inflammatory cytokines, intestinal flora level and incidence of adverse reactions were compared between the two groups.
The total effective rate of the observation group was 92.16%, which was significantly higher than 76.47% of the control group (P < 0.05). The disappearance time of symptoms of fever, cough, shortness of breath, chest tightness and chest pain and hospital stay in the observation group were significantly shorter than those in the control group (P < 0.05). After treatment, the levels of cardiac troponin T (cTnT), B-type natriuretic peptide (BNP), myoglobin (Mb) and cardiac fatty acid binding protein (H-FABP) in the observation group were significantly lower than those in the control group(P < 0.05); the levels of interleukin-1 receptor 1(IL-1R1), gamma-interferon (γ-IFN) and high mobility group protein 1(HMGB1) in the observation group were significantly lower than those inthe control group (P < 0.05); the number of Bifidobacteria, Lactobacillus acidophilus, Enterococcus faecalis and Bacillus cereus in the observation group were significantly higher than the control group, while the number of Escherichia coli and Salmonella were significantly lower than those in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).
Probiotics combined with montelukast have good efficacy in MPP children with myocardial injury, which can shorten the time of symptom resolution and hospital stay, improve the indexes of myocardial injury in children, inhibit the level of inflammatory cytokines, adjust the structure of intestinal flora disorder, and have good safety.
[1] |
FUJITA J. Mycoplasma pneumoniae pneumonia and respiratory syncytial virus infection in Japan during the severe acute respiratory syndrome coronavirus 2 pandemic[J]. Respir Investig, 2021, 59(1): 5-7. doi: 10.1016/j.resinv.2020.11.002
|
[2] |
MENG F, CHEN P, GUO X, et al. Correlations between Serum P2X7, Vitamin A, 25 ydroxy Vitamin D, and Mycoplasma Pneumoniae Pneumonia[J]. Journal of Clinical Laboratory Analysis, 2021, 29(1): 182-189.
|
[3] |
苏永红, 孙雪丽, 杨丽丽, 等. 肺炎支原体肺炎患儿并发心肌损害的危险因素研究[J]. 中国中西医结合儿科学, 2022, 14(4): 323-325.
|
[4] |
IWANAGA Y, YAMASAKI K, NEMOTO K, et al. Combined radiographic features and age can distinguish Mycoplasma pneumoniae pneumonia from other bacterial pneumonias: analysis using the 16S rRNA gene sequencing data[J]. J Clin Med, 2022, 11(8): 2201. doi: 10.3390/jcm11082201
|
[5] |
梁少霞. 儿童肺炎支原体肺炎采用孟鲁司特钠辅助治疗的效果[J]. 世界复合医学, 2022, 8(1): 135-137, 141.
|
[6] |
胡尧舜, 高广川, 李小容, 等. 肺炎支原体肺炎患儿肠道菌群与血清干扰素-γ和白介素-4水平的关系[J]. 西部医学, 2021, 33(11): 1687-1690.
|
[7] |
胡亚美, 江载芳. 诸福棠实用儿科学[M]. 7版. 北京: 人民卫生出版社, 2002: 632-635.
|
[8] |
魏贤. 心肌损伤标志物联合检测对急性病毒性心肌炎的诊断[J]. 中国医药指南, 2018, 16(19): 126-127.
|
[9] |
中华人民共和国国家健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志, 2019, 12(1): 6-13.
|
[10] |
范玉洁, 俞怡雪, 李玉琴, 等. 儿童肺炎支原体肺炎中MP载量的临床意义及可能发病机制[J]. 临床肺科杂志, 2021, 26(8): 1203-1207.
|
[11] |
李朝友, 朱蓉, 昌兰, 等. 孟鲁司特钠佐治小儿支原体肺炎临床观察[J]. 中国药业, 2022, 31(22): 81-83.
|
[12] |
范超. 醒脾养儿颗粒结合双歧杆菌三联活菌胶囊治疗小儿肺炎继发性腹泻的效果探讨[J]. 中国校医, 2019, 33(9): 689-691.
|
[13] |
曹炎炎, 张荣, 孙兵, 等. 双歧杆菌三联活菌联合地塞米松治疗重症肺炎效果观察[J]. 新疆医科大学学报, 2020, 43(12): 1571-1575.
|
[14] |
张春. 阿奇霉素序贯治疗联合双歧杆菌三联活菌散对肺炎患儿的疗效探析[J]. 北方药学, 2019, 16(10): 14-16.
|
[15] |
马晔. 阿奇霉素联合益生菌治疗小儿支原体肺炎合并腹泻的临床疗效[J]. 中国现代药物应用, 2021, 15(9): 167-169.
|
[16] |
李金妞, 贾华华, 张攀, 等. 新生儿窒息后血清肌钙蛋白Ⅰ、血浆脑钠肽、心脏Tei指数变化及评估心肌损伤价值[J]. 中国计划生育学杂志, 2022, 30(6): 1379-1382.
|
[17] |
康静, 王斐, 靳秀花, 等. 新生儿窒息后血清CK-MB、CT-1及H-FABP判断心肌损伤的价值[J]. 西部医学, 2022, 34(7): 1069-1072.
|
[18] |
庞凌燕, 陈燕, 孙怡婷. 联合益生菌方案治疗肺炎支原体肺炎继发腹泻患儿的疗效及对患儿临床病程的影响[J]. 中国妇幼保健, 2020, 35(21): 4039-4041.
|
[19] |
邹蓉. 肺炎支原体肺炎患儿血清IL-1R1、HMGB1、炎症细胞因子水平及其临床意义[J]. 中国现代医学杂志, 2021, 31(12): 7-11.
|
[20] |
张玉新, 杨兴鸽. 小儿肺炎支原体肺炎血清IFN-γ、IL-10、维生素A水平特征及临床意义[J]. 医药论坛杂志, 2021, 42(16): 32-36.
|
[21] |
WU Z W, ZHANG Z X, WANG Z H, et al. miR-181a-5p alleviates the inflammatory response of PC12 Cells by inhibiting high-mobility group box-1 protein expression[J]. World Neurosurg, 2022, 162: e427-e435.
|
1. |
马建伟,薛晶,王文革,胡俊泽,罗小丽. hsa_circ_401724表达与2型糖尿病患者的炎症反应及与胰岛细胞功能的关系研究. 国际检验医学杂志. 2024(04): 426-429+434 .
![]() | |
2. |
刘金虹,赵杰,刘长鑫. 环状RNA对乳腺癌调控作用的研究进展. 感染、炎症、修复. 2024(04): 335-340 .
![]() | |
3. |
王浩,李南林,曹海玲. 循环肿瘤细胞与三阴性乳腺癌预后及肿瘤状态的关系分析. 实用临床医药杂志. 2023(18): 39-43 .
![]() |